Functional assay of plasma antithrombin using polyethylene glycol (PEG) defibrinated plasma.
Polyethylene glycol(PEG) was used to precipitate fibrinogen to prepare defibrinated plasma in the two stage clotting assay of antithrombin activity. Five percent PEG-8000 precipitated fibrinogen from plasma without loss of antithrombin activity in the defibrinated plasma. Fibrin degradation products(FDP) as high as 640 ug/ml did not interfere the two stage clotting assay using PEG defibrinated plasma possibly because part of FDP was precipitated by PEG in the process of plasma defibrination. The two stage clotting assay was very sensitive to the changes of antithrombin activity in the range of 60%-100% of normal level. The assay was reproducible and correlated with chromogenic assay. The decrease of plasma antithrombin activity in a baboon septic shock model was demonstrated with this assay.
D000818:Animals; D000990:Antithrombin III / Q000032:analysis*; D001681:Biological Assay / Q000379:methods* / Q000706:statistics & numerical data; D011232:Chemical Precipitation; D004195:Disease Models, Animal; D005069:Evaluation Studies as Topic; D005340:Fibrinogen / Q000302:isolation & purification; D006801:Humans; D066298:In Vitro Techniques; D010215:Papio; D010949:Plasma / Q000737:chemistry; D011092:Polyethylene Glycols; D012680:Sensitivity and Specificity; D012772:Shock, Septic / Q000097:blood
D011092:Polyethylene Glycols; D000990:Antithrombin III; D005340:Fibrinogen